Lots of companies are feverishly working to develop products to manage and treat diabetes. Many of these companies are publicly traded. We asked three Motley Fool healthcare contributors to pick the top diabetes stocks they think investors should especially watch in March. Here's why they chose AstraZeneca (NYSE: AZN), DexCom (NASDAQ: DXCM), and Medtronic (NYSE: MDT).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,